6,146
Views
31
CrossRef citations to date
0
Altmetric
Review Articles

How efficient is resveratrol as an antioxidant of the Mediterranean diet, towards alterations during the aging process?

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon &
Pages 1101-1112 | Received 25 Feb 2019, Accepted 24 Apr 2019, Published online: 07 Oct 2019

References

  • Estruch R, Salas-Salvadó J. Towards an even healthier Mediterranean diet. Nutr Metab Cardiovasc Dis. 2013;23:1163–1166.
  • Berrino F. Mediterranean diet and its association with reduced invasive breast cancer risk. JAMA Oncol. 2016;2:535–536.
  • Grosso G, Biondi A, Galvano F, et al. Factors associated with colorectal cancer in the context of the Mediterranean diet: a case-control study. Nutr Cancer. 2014;66:558–565.
  • Boccardi V, Esposito A, Rizzo MR, et al. Mediterranean diet, telomere maintenance and health status among elderly. PLOS ONE. 2013;8:e62781.
  • Takaoka M. Phenolic substances of white hellebore (Veratrum grandiflorum loes. Fil.). J Faculty Sci. Hokkaïdo Imperial Univ. 1940;3:1–16.
  • Nonomura S, Kanagawa H, Makimoto A. Chemical constituents of polygonaceous plants. I. Studies on the components of Ko-J O-kon. (Polygonum Cuspidatum Sieb. Et Zucc.). Yakugaku Zasshi. 1963;83:988–990.
  • Langcake P, Pryce RJ. The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol Plant Pathol. 1976;9:77–86.
  • Delmas D, Jannin B, Latruffe N. Resveratrol: preventing properties against vascular alterations and ageing. Mol Nutr Food Res. 2005;49:377–395.
  • Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337–342.
  • Magyar K, Halmosi R, Palfi A, et al. Cardioprotection by resveratrol: a human clinical trial in patients with stable coronary artery disease. Clin Hemorheol Microcirc. 2012;50:179–187.
  • Carrizzo A, Puca A, Damato A, et al. Resveratrol improves vascular function in patients with hypertension and dyslipidemia by modulating no metabolism. Hypertension. 2013;62:359–366.
  • Tomé-Carneiro J, Gonzálvez M, Larrosa M, et al. Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and A po B in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial. Mol Nutr Food Res. 2012;56:810–821.
  • Tomé-Carneiro J, Gonzálvez M, Larrosa M, et al. Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease. Cardiovasc Drugs Ther. 2013;27:37–48.
  • Pollack RM, Barzilai N, Anghel V, et al. Resveratrol improves vascular function and mitochondrial number but not glucose metabolism in older adults. J Gerontol A Biol Sci Med Sci. 2017;72:1703–1709.
  • Faghihzadeh F, Adibi P, Hekmatdoost A. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study. Br J Nutr. 2015;114:796–803.
  • Zamora-Ros R, Urpi-Sarda M, Lamuela-Raventós RM, et al. High urinary levels of resveratrol metabolites are associated with a reduction in the prevalence of cardiovascular risk factors in high-risk patients. Pharmacol Res. 2012;65:615–620.
  • Rabassa M, Zamora-Ros R, Urpi-Sarda M, et al. Association of habitual dietary resveratrol exposure with the development of frailty in older age: the Invecchiare in Chianti study. Am J Clin Nutr. 2015;102:1534–1542.
  • Semba RD, Ferrucci L, Bartali B, et al. Resveratrol levels and all-cause mortality in older community-dwelling adults. JAMA Intern Med. 2014;174:1077–1084.
  • Kjaer TN, Ornstrup MJ, Poulsen MM, et al. No beneficial effects of resveratrol on the metabolic syndrome: a randomized placebo-controlled clinical trial. J Clin Endocrinol Metab. 2017;102:1642–1651.
  • Gliemann L, Nyberg M, Hellsten Y. Effects of exercise training and resveratrol on vascular health in aging. Free Radic Biol Med. 2016;98:165–176.
  • Alway SE, McCrory JL, Kearcher K, et al. Resveratrol enhances exercise-induced cellular and functional adaptations of skeletal muscle in older men and women. J Gerontol A Biol Sci Med Sci. 2017;72:1595–1606.
  • Gliemann L, Schmidt JF, Olesen J, et al. Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men. J Physiol. 2013;591:5047–5059.
  • Nussbaum RL, Ellis CE. Alzheimer’s disease and Parkinson’s disease. N Engl J Med. 2003;348:1356–1364.
  • Liang HW, Zhang JF, Zen K, et al. Nuclear microRNAs and their unconventional role in regulating non-coding RNAs. Protein Cell. 2013;4:325–330.
  • Gao J, Wang WY, Mao YW, et al. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature. 2010;466:1105–1109.
  • Zhao YN, Li WF, Li F, et al. Resveratrol improves learning and memory in normally aged mice through microRNA-CREB pathway. Biochem Biophys Res Commun. 2013;435:597–602.
  • Rahvar M, Nikseresht M, Shafiee SM, et al. Effect of oral resveratrol on the BDNF gene expression in the hippocampus of the rat brain. Neurochem Res. 2011;36:761–765.
  • Navarro-Cruz AR, Ramírez Y Ayala R, Ochoa-Velasco C, et al. Effect of chronic administration of resveratrol on cognitive performance during aging process in rats. Oxid Med Cell Longev. 2017;2017:8510761.
  • Dal-Pan A, Pifferi F, Marchal J, et al. Cognitive performances are selectively enhanced during chronic caloric restriction or resveratrol supplementation in a primate. PLOS ONE. 2011;6:e16581.
  • Boldrini M, Fulmore CA, Tartt AN, et al. Human hippocampal neurogenesis persists throughout aging. Cell Stem Cell. 2018;22:589–599.e5.
  • Torres-Pérez M, Tellez-Ballesteros RI, Ortiz-López L, et al. Resveratrol enhances neuroplastic changes, including hippocampal neurogenesis, and memory in Balb/c mice at six months of age. PLoS One. 2015;10:e0145687.
  • Burke RE. Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: two approaches with therapeutic potential in the treatment of neurodegenerative disease. Pharmacol Ther. 2007;114:261–277.
  • Pascale A, Amadio M, Govoni S, et al. The aging brain, a key target for the future: the protein kinase C involvement. Pharmacol Res. 2007;55:560–569.
  • Kodali M, Parihar VK, Hattiangady B, et al. Resveratrol prevents age-related memory and mood dysfunction with increased hippocampal neurogenesis and microvasculature, and reduced glial activation. Sci Rep. 2015;5:8075.
  • Oomen CA, Farkas E, Roman V, et al. Resveratrol preserves cerebrovascular density and cognitive function in aging mice. Front Aging Neurosci. 2009;1:4.
  • Sarubbo F, Ramis MR, Aparicio S, et al. Improving effect of chronic resveratrol treatment on central monoamine synthesis and cognition in aged rats. Age (Dordr). 2015;37:9777.
  • Patterson SLJN. Immune dysregulation and cognitive vulnerability in the aging brain: interactions of microglia, IL-1β, BDNF and synaptic plasticity. Neuropharmacology. 2015;96:11–18.
  • Gocmez SS, Gacar N, Utkan T, et al. Protective effects of resveratrol on aging-induced cognitive impairment in rats. Neurobiol Learn Mem. 2016;131:131–136.
  • Islam MT. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurol Res. 2017;39:73–82.
  • Salim S. Oxidative stress and the central nervous system. J Pharmacol Exp Ther. 2017;360:201–205.
  • Santos JA, de Carvaho GS, Oliveira V, et al. Resveratrol and analogues: a review of antioxidant activity and applications to human health. Recent Pat Food Nutr Agric. 2013;5:144–153.
  • Liu GS, Zhang ZS, Yang B, et al. Resveratrol attenuates oxidative damage and ameliorates cognitive impairment in the brain of senescence-accelerated mice. Life Sci. 2012;91:872–877.
  • Carrasco-Garcia E, Moreno-Cugnon L, Garcia I, et al. SOX2 expression diminishes with ageing in several tissues in mice and humans. Mech Ageing Dev. 2019;177:30–36.
  • Yu X, Li G. Effects of resveratrol on longevity, cognitive ability and aging-related histological markers in the annual fish Nothobranchius guentheri. Exp Gerontol. 2012;47:940–949.
  • Kennedy DO, Wightman EL, Reay JL, et al. Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am J Clin Nutr. 2010;91:1590–1597.
  • Huhn S, Beyer F, Zhang R, et al. Effects of resveratrol on memory performance, hippocampus connectivity and microstructure in older adults–A randomized controlled trial. Neuroimage. 2018;174:177–190.
  • Wong RH, Berry NM, Coates AM, et al. Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults. J Hypertens. 2013;31:1819–1827.
  • Evans HM, Howe PR, Wong RH. Effects of resveratrol on cognitive performance, mood and cerebrovascular function in post-menopausal women; a 14-week randomised placebo-controlled intervention trial. Nutrients. 2017;9:27.
  • Farzaei MH, Rahimi R, Nikfar S, et al. Effect of resveratrol on cognitive and memory performance and mood: a meta-analysis of 225 patients. Pharmacol Res. 2018;128:338–344.
  • Marx W, Kelly JT, Marshall S, et al. Effect of resveratrol supplementation on cognitive performance and mood in adults: a systematic literature review and meta-analysis of randomized controlled trials. Nutr Rev. 2018;76:432–443.
  • Pawate S, Shen Q, Fan F, et al. Redox regulation of glial inflammatory response to lipopolysaccharide and interferon γ. J Neurosci Res. 2004;77:540–551.
  • Perry VH, Teeling J. Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration. Semin Immunopathol. 2013;35(5):601–612. DOI:10.1007/s00281-013-0382-8
  • Cunningham C. Microglia and neurodegeneration: the role of systemic inflammation. Glia. 2013;61:71–90.
  • Kou X, Chen NJN. Resveratrol as a natural autophagy regulator for prevention and treatment of Alzheimer’s disease. Nutrients. 2017;9:927.
  • McKenzie JA, Spielman LJ, Pointer CB, et al. Neuroinflammation as a common mechanism associated with the modifiable risk factors for Alzheimer’s and Parkinson’s diseases. Curr Aging Sci. 2017;10:158–176.
  • Morris MC, Evans DA, Tangney CC, et al. Associations of vegetable and fruit consumption with age-related cognitive change. Neurology. 2006;67:1370–1376.
  • Scarmeas N, Stern Y, Tang MX, et al. Mediterranean diet and risk for Alzheimer’s disease. Ann Neurol. 2006;59:912–921.
  • Alcalay RN, Gu Y, Mejia-Santana H, et al. The association between Mediterranean diet adherence and Parkinson’s disease. Mov Disord. 2012;27:771–774.
  • Singh B, Parsaik AK, Mielke MM, et al. Association of Mediterranean diet with mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis. 2014;39:271–282.
  • Anastasiou CA, Yannakoulia M, Kosmidis MH, et al. Mediterranean diet and cognitive health: initial results from the Hellenic Longitudinal Investigation of Ageing and Diet. PLOS ONE. 2017;12:e0182048.
  • Katz Sand I. The role of diet in multiple sclerosis: mechanistic connections and current evidence. Curr Nutr Rep. 2018;7:150–160.
  • Casamenti F, Stefani M. Olive polyphenols: new promising agents to combat aging-associated neurodegeneration. Expert Rev Neurother. 2017;17:345–358.
  • Caruana M, Cauchi R, Vassallo NJ. Putative role of red wine polyphenols against brain pathology in Alzheimer’s and Parkinson’s disease. Front Nutr. 2016;3:31.
  • Capiralla H, Vingtdeux V, Zhao H, et al. Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade. J Neurochem. 2012;120:461–472.
  • Chen J, Zhou Y, Mueller-Steiner S, et al. SIRT1 protects against microglia-dependent amyloid-β toxicity through inhibiting NF-κB signaling. J Biol Chem. 2005;280:40364–40374.
  • Zhong LM, Zong Y, Sun L, et al. Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells. PLOS ONE. 2012;7:e32195.
  • Maiuri MC, De Stefano D, Di Meglio P, et al. Hydroxytyrosol, a phenolic compound from virgin olive oil, prevents macrophage activation. Naunyn Schmiedebergs Arch Pharmacol. 2005;371:457–465.
  • Candelario-Jalil E, de Oliveira AC, Gräf S, et al. Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia. J Neuroinflamm. 2007;4:25.
  • Lorenz P, Roychowdhury S, Engelmann M, et al. Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: effect on nitrosative and oxidative stress derived from microglial cells. Nitric Oxide. 2003;9:64–76.
  • Bi XL, Yang JY, Dong YX, et al. Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. Int Immunopharmacol. 2005;5:185–193.
  • Steiner N, Balez R, Karunaweera N, et al. Neuroprotection of Neuro2a cells and the cytokine suppressive and anti-inflammatory mode of action of resveratrol in activated RAW264. 7 Macrophages and C8 − B4 microglia. Neurochem Int. 2016;95:46–54.
  • Ye J, Liu Z, Wei J, et al. Protective effect of SIRT1 on toxicity of microglial-derived factors induced by LPS to PC12 cells via the p53-caspase-3-dependent apoptotic pathway. Neurosci Lett. 2013;553:72–77.
  • Diaz-Ruiz C, Rodriguez-Perez AI, Beiroa D, et al. Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: implications for aging and neurodegeneration. Oncotarget. 2015;6:26675–26689.
  • Zhang F, Shi JS, Zhou H, et al. Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions. Mol Pharmacol. 2010;78:466–477.
  • Cianciulli A, Dragone T, Calvello R, et al. IL-10 plays a pivotal role in anti-inflammatory effects of resveratrol in activated microglia cells. Int Immunopharmacol. 2015;24:369–376.
  • Tili E, Michaille JJ, Adair B, et al. Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. Carcinogenesis. 2010;31:1561–1566.
  • Cano M, Thimmalappula R, Fujihara M, et al. Cigarette smoking, oxidative stress, the anti-oxidant response through Nrf2 signaling, and Age-related Macular Degeneration. Vision Res. 2010;50:652–664.
  • Sheu SJ, Liu NC, Chen JL. Resveratrol protects human retinal pigment epithelial cells from acrolein-induced damage. J Ocul Pharmacol Ther. 2010;26:231–236.
  • Pintea A, Rugină D, Pop R, et al. Antioxidant effect of trans-resveratrol in cultured human retinal pigment epithelial cells. J Ocul Pharmacol Ther. 2011;27:315–321.
  • Zheng Y, Liu Y, Ge J, et al. Resveratrol protects human lens epithelial cells against H2O2-induced oxidative stress by increasing catalase, SOD-1, and HO − 1 expression. Mol Vis. 2010;16:1467–1474.
  • Kubota S, Kurihara T, Mochimaru H, et al. Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor–κB activation. Invest Ophthalmol Vis Sci. 2009;50:3512–3519.
  • Losso JN, Truax RE, Richard G. Trans-resveratrol inhibits hyperglycemia-induced inflammation and connexin downregulation in retinal pigment epithelial cells. J Agric Food Chem. 2010;58:8246–8252.
  • Luna C, Li G, Liton PB, et al. Resveratrol prevents the expression of glaucoma markers induced by chronic oxidative stress in trabecular meshwork cells. Food Chem Toxicol. 2009;47:198–204.
  • Dugas B, Charbonnier S, Baarine M, et al. Effects of oxysterols on cell viability, inflammatory cytokines, VEGF, and reactive oxygen species production on human retinal cells: cytoprotective effects and prevention of VEGF secretion by resveratrol. Eur J Nutr. 2010;49:435–446.
  • Latruffe N, Lançon A, Limagne E, et al. Bioreactivity of resveratrol toward inflammation processes. In: Jacob C, Kirsch G, Slusarenko AJ, et al., editors. Recent advances in redox active plant and microbial products. Dordrecht: Springer; 2014. p. 193–207.
  • Richer S, Stiles W, Ulanski L, et al. Observation of human retinal remodeling in octogenarians with a resveratrol based nutritional supplement. Nutrients. 2013;5:1989–2005.
  • Richer S, Patel S, Sockanathan S, et al. Resveratrol based oral nutritional supplement produces long-term beneficial effects on structure and visual function in human patients. Nutrients. 2014;6:4404–4420.
  • de la Lastra CA, Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans. 2007;35:1156–1160.